Definitive Contract 75N91019C00018
Award Date 9/16/19
Potential Completion Date 8/15/22
Potential Value $2.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $399,951 firm-fixed-price definitive contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the small business Care Progress LLC. The contract supports the development of "BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY" under the NCI's Small Business Innovation Research (SBIR) program, which is a set-aside for small businesses. Care Progress LLC, a for-profit limited liability company, has previously...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $1,724,411.00 Firm Fixed Price, Phase I Small Business Innovation Research (SBIR) contract to Care Progress LLC, a for-profit limited liability company. The contract is for the development of digital platforms to support informal cancer caregiving, connecting cancer caregivers to care teams. Care Progress LLC has previous experience in developing participant engagement platforms for...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Care Progress LLC, a for-profit small business, to develop technology solutions to improve long-term care for cancer survivors under the Cancer Moonshot initiative. The $224,875 Firm Fixed Price contract was a Small Business Innovation Research (SBIR) Phase I award, with a completion date of June 15, 2020. Care Progress LLC has previously received other...
- This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Cancer Institute to Carevive Systems Inc., a woman-owned small business. The contract, valued at $1,725,000.00, is for the development of "Symptom Management and Intervention Roadmaps (STAIRS) (MOONSHOT)" to contribute toward meeting the program objectives of the NIH and Centers for Disease Control and Prevention...
- This is a $1,499,973.00 Small Business Innovation Research (SBIR) Phase II contract awarded to Charles River Analytics, Inc., a small business located in Cambridge, Massachusetts. The contract was awarded by the National Cancer Institute, a civilian federal agency, to develop connected health technologies to address and improve health outcomes for long-term cancer survivors. The contract has a performance period of September 13, 2021 to September 12, 2023, with an ultimate completion date of...
- This is a $867,688.86 federal contract awarded by the National Cancer Institute (NCI) to Dimagi Inc., a global social enterprise that develops digital health solutions and data collection software. The contract is a Small Business Innovation Research (SBIR) Phase II award for the development of a system to coordinate and track home-based chronic care for cancer patients. Dimagi, a self-certified small disadvantaged business, is the prime contractor on this cost-plus-fixed-fee definitive...
- This is a $300,000 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Coordination Pharmaceuticals Inc., a small business. The contract is for the detection, diagnosis, treatment, prevention, and research of pediatric cancers and/or rare cancers. It was awarded under a Small Business Innovation Research (SBIR) Concept Award Program, which is a "Phase 0" pilot program intended to encourage small businesses to develop innovative and...
- The National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Navipoint Genomics LLC, a minority-owned small business, under the SBIR Program Phase II. The contract, valued at $1,679,321.00, is for the development of cloud-based software to support the Cancer Research Data Commons project. This project aims to enable precision oncology by facilitating collaboration in the cloud. The contract has a completion date of May 31, 2025 and is set aside for small businesses.